[Ed. Note – This article does not meet our new editorial guidelines, nor does the company mentioned meet our investment criteria. It will be removed from the site in the future.]

Venus Remedies (BSE:526953) (NSE:VENUSREM) has secured a patent from Mexico for its new antibiotic product Potentox. The patent has been granted by the Mexican Institute of Industrial property, and it safeguards the composition of Potentox.… Read more